Cargando…
Cross-over—it's a feature, not a bug
Pharmaceutical companies, investigators, regulators, and payers need to work together to adapt standards for drug development that meet the needs of all stakeholders, but first and foremost, benefit cancer patients in the most appropriate way.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551154/ https://www.ncbi.nlm.nih.gov/pubmed/26078468 http://dx.doi.org/10.1093/annonc/mdv260 |
| _version_ | 1782387542019014656 |
|---|---|
| author | Engelsberg, A. |
| author_facet | Engelsberg, A. |
| author_sort | Engelsberg, A. |
| collection | PubMed |
| description | Pharmaceutical companies, investigators, regulators, and payers need to work together to adapt standards for drug development that meet the needs of all stakeholders, but first and foremost, benefit cancer patients in the most appropriate way. |
| format | Online Article Text |
| id | pubmed-4551154 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45511542015-08-28 Cross-over—it's a feature, not a bug Engelsberg, A. Ann Oncol Industry Corner: Perspectives and Controversies Pharmaceutical companies, investigators, regulators, and payers need to work together to adapt standards for drug development that meet the needs of all stakeholders, but first and foremost, benefit cancer patients in the most appropriate way. Oxford University Press 2015-09 2015-06-15 /pmc/articles/PMC4551154/ /pubmed/26078468 http://dx.doi.org/10.1093/annonc/mdv260 Text en © The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Industry Corner: Perspectives and Controversies Engelsberg, A. Cross-over—it's a feature, not a bug |
| title | Cross-over—it's a feature, not a bug |
| title_full | Cross-over—it's a feature, not a bug |
| title_fullStr | Cross-over—it's a feature, not a bug |
| title_full_unstemmed | Cross-over—it's a feature, not a bug |
| title_short | Cross-over—it's a feature, not a bug |
| title_sort | cross-over—it's a feature, not a bug |
| topic | Industry Corner: Perspectives and Controversies |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551154/ https://www.ncbi.nlm.nih.gov/pubmed/26078468 http://dx.doi.org/10.1093/annonc/mdv260 |
| work_keys_str_mv | AT engelsberga crossoveritsafeaturenotabug |